Jaff Investment Company * holds a majority interest in United States patents covering laminate dental veneers and their manufacturing methods. Chameleon Dental Products, Inc., is a company that makes porcelain laminаte veneers. Chameleon sold the materials and trained dental laboratories to apply the veneers.
In September 1984, Jaff brought a federal suit against Myron’s Dental Laboratories (owner of Chameleon) for patent infringement. This lawsuit was settled on November 3, 1984. Myron’s Dental Laboratories (on behalf of Chameleon) and Jaff agreed to the entry of a consent decree which established the validity of the Jaff patents and Myron’s infringement of those patents. As a part of the settlement provisions, the parties executed three licensing agreements between Deсember 1984, and April 1985.
The first agreement, the Training Program Agreement, granted Chameleon a license to train Jaff's licensees in exchange for a specific payment for each laborаtory location trained. Jaff also agreed to pay Chameleon certain royalty payments whenever Jaff granted a license under one of its patents. The second agreemеnt, the Chameleon License Agreement, granted Chameleon a license for the use of the Jaff patents. Two of Chameleon’s facilities would operate royalty-free with respect to orders from a dentist or a licensed laboratory. A third agreement, the Laboratory License Agreement, licensed Chameleon’s new California lab and required it to pay royalties to Jаff.
Each of the three agreements contained an arbitration provision. The pertinent part for our purposes states:
If any matter involving claims and/or disputes or other question arising out of, or relating to this Agreement or to a breach hereof or default hereunder can not be settled by mutual agreement ... such matter may be submitted to arbitration in accordance with the practice and procedure of the American Arbitration Association then in force, and this Agreement so to arbitrate shall be specifically, enforceable.
In mid-1985, Jaff claimed that Chamеleon was not complying with the terms of the Training Program Agreement. Jaff asserted that Chameleon was training unlicensed laboratories in violation of the agreement, thus causing Chameleon lost rоyalties. Jaff also alleged that Chameleon had fallen behind in its submission of reports and royalties. Jaff also alleged that Chameleon failed to establish FDA approval of all materials, was delinquent in forwarding to Jaff certifications indicating that certain labs had successfully completed their training, and failed to provide, and keep Jaff informed of, proper training. Based on these claims Jaff unilaterally claimed the Training Program Agreement to be terminated on August 7, 1985.
A little over five months later on January 24, 1986, Chameleon asserted wrongful termination of the Training Program Agreement and demanded arbitration. *225 Jaff responded with a counterclaim. In addition, Jaff also claimed termination of the Chameleon License Agreement on February 26, 1986, asserting that Chameleon assisted оthers in infringing on Jaff s patents. Shortly thereafter, Jaff asserted unilateral termination of the Laboratory License Agreement, again alleging that Chameleon assisted others in patent infringement and failed adequately to explain royalty calculations.
The entire matter was submitted to an arbitration panel of the American Arbitration Association on July 28-30, 1986. On September 29, 1986, the arbitration panel declared the three disputed licensing agreements to be terminated, awarded damages to Chameleon of $73,056 for wrongfully withheld royalties, and denied Jaff any damages.
Chameleon returned to federal court on December 31, 1986, filing a motion to “Confirm in Part and Vacate in Part the Arbitration Award” in which they alleged that the arbitrators exceeded the scope of their powers in terminating all three agreements. The district court rejected Chameleon’s request and confirmed the entire arbitration award.
The chances for a successful appeal of an arbitrаtion award are not particularly good. As the district court correctly noted, judicial review of arbitration awards is extremely limited. When asked to set aside an arbitration award, our review is rеstricted to determining whether the arbitrator actually interpreted the contract.
Hill v. Norfolk & W. Ry. Co.,
Chameleon acknowledges the substantial restrictions it faces in contesting the arbitration award but claims that the arbitrators in this case went beyond the terms of the Training Prоgram Agreement when they declared its termination. The Chameleon License Agreement and the Laboratory License Agreement — but not the Training Program Agreement — contained specific provisions for early termination. Chameleon asserts that because the Training Program Agreement had no termination provision the arbitrators were powerless to declare it terminated.
Mоreover, each of the three agreements also contained a “life of the patent” provision as the “term” for which the agreement was to remain in effect. Chameleon argues that the specific “life of the patent” term in the Training Program Agreement prohibited its termination prior to the expiration of relevant patents.
Once the arbitrators found violations of the agreements (which they obviously did), they were required to formulate an appropriate remedy. The remedy they decided upon, as we have noted, was to financially compensate Chameleon through a damage award of $73,056 and to terminate all three licensing agreements.
There were, in fact, no explicit provisions in the Training Program Agreement authorizing early terminatiоn or any other remedies for a breach. However, where such contractual voids exist, arbitrators are given wide latitude in fashioning an appropriate remedy.
Id.; Mogge v. District 8, Int’l Ass’n of Machinists,
In this case, the fact that the term of the agreement was for the life of the relevant patents cannot be fairly read to preclude or prohibit early termination for a breаch. More importantly, however, the exercise in forming such a decision about early termination is exactly the type of contractual interpretation which arbitrators are charged with carrying out — and courts are prohibited from second-guessing. The decision by the arbitrators to terminate the Training Program Agreement, as well as the other two agreements, was within the latitude given them fоr fashioning an appropriate remedy.
In seeking to vacate the arbitration award Chameleon also urges us to adopt the so-called “manifest disregard of the law” exception to the statutory review provisions of the Arbitration Act, 9 U.S.C. § 1,
et seq.
However, we have consistently held that the exclusive grounds for vacating or modifying a commercial arbitration award are found in §§ 10 and 11 of the Arbitration Act.
See Moseley, Hallgarten, Estabrook & Weeden v. Ellis,
Chameleon’s dispute with Jaff as expressed in this lawsuit is inextricably bound up with an interpretation of the Training Program Agreement and its reasonable accommodation of early termination for a breach. The parties anticipated that any disputes regаrding their agreements would be resolved by arbitration. As they had foreseen, when disputes arose an interpretation of the agreement was made by the arbitrators — who reached a remedy consistent with their duty of contractual interpretation. We may not re-exercise such an interpretation. As the district court pointed out, arbitration is not meant to be an added preliminary step to judicial resolution of commercial disputes.
The decision of the district court is Affirmed.
Notes
Jaff Investment Company was originally a partnership established by James L. Jackson, Albert R. Faunce, and Frank R. Faunce. Subsequent to the underlying action Jaff became an Indiana corporation.